Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC [NA]
The CRUCIAL-R study is evaluating a cruciferous vegetables dietary regimen for non-muscle-invasive bladder cancer, with the trial currently …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer [NA]
A clinical trial update for Hydeal Cyst intravesical instillations in non-muscle invasive bladder cancer patients previously treated with in…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating whether a cruciferous vegetable eating program can reduce recurrence and progression in patients with non-…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial update notes that intravesical instillation of TARA-002 for high-grade non-muscle invasive bladder cancer is curren…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve [Phase 1, Phase 2]
A Phase 1/2 study (LEGEND Study: EG-70) is recruiting to evaluate EG-70 in non-muscle invasive bladder cancer, including patients with carci…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Phase II Prospective Cohort Study of Intravesical Recombinant Human Type 5 Adenovirus Injection for Treatment of High-Risk Non-Muscle Invasive Bladder Cancer: Evaluating Efficacy and Safety [Phase 2]
Phase II prospective cohort study evaluating intravesical recombinant human adenovirus type 5 injection for high-risk non-muscle invasive bl…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer [Phase 3]
This entry reports a Phase 3 trial of UGN-103 for low-grade, intermediate-risk non-muscle invasive bladder cancer and indicates the study is…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study [NA]
A sequential mixed-methods intervention trial to support sexual health in bladder cancer patients, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676) [Phase 3]
This entry describes a phase 3 clinical trial (MK-3475-676/KEYNOTE-676) evaluating pembrolizumab in combination with intravesical Bacillus C…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase II trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Sarcopenia and NMIBC Prognosis Study
A clinical trial update for a study examining the prognostic impact of sarcopenia in non-muscle invasive bladder cancer. The study is not ye…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer. [Phase 3]
A Phase III randomized trial compares radiotherapy with radiosensitisation versus intravesical Bacillus Calmette-Guérin therapy for high-ris…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC [Phase 1]
Phase 1 clinical trial evaluating intravesical adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) for BCG-exposed high-grade n…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: The Role of Universal Cancer Only Marker SIX6 in Diagnosing Non-Muscle Invasive Bladder Cancer [NA]
This clinical trial update reports on investigating SIX6 as a universal cancer biomarker for diagnosing non-muscle invasive bladder cancer, …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients [Phase 2]
Phase 2 clinical trial update on intravesical photodynamic therapy for non-muscle invasive bladder cancer patients unresponsive or intoleran…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients [NA]
A clinical trial update describing Hyperthermic Intravesical Chemotherapy (HIVEC) for high-grade non-muscle invasive bladder cancer that is …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG
A clinical trial update notes mood alterations in patients with non-muscle invasive bladder cancer treated with intravesical BCG. The study …
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC) [Phase 3]
This document announces the recruitment for a Phase 3 clinical trial comparing standard treatments in people with non-muscle invasive bladde…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer [Phase 2, Phase 3]
A multicenter Phase 2/3 clinical trial evaluating intravesical Bacillus Calmette-Guerin in combination with ALT-803 (N-803) for BCG-unrespon…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating Ablation Therapy for intermediate-risk non-muscle invasive bladder cancer. The stu…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC [Phase 3]
Phase 3 trial update for DV in combination with Bacillus Calmette-Guérin in HER2-expressing, BCG-naïve high-risk non-muscle invasive bladder…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer [Phase 4]
Phase 4 clinical trial comparing chemoablation or bladder resection with adjuvant chemotherapy for recurrent non-muscle invasive bladder can…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial [Phase 2, Phase 3]
A randomized Phase 2/3 trial is evaluating submucosal gemcitabine injections to prevent recurrence in patients with intermediate- and high-r…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study [Phase 2]
This update describes an open-label, randomized Phase 2 trial evaluating toripalimab with or without sequential intravesical gemcitabine-mit…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer [NA]
A clinical trial evaluating whether urine tumor DNA can be used to de-intensify surveillance in patients with non-muscle invasive bladder ca…